The DoD is offering a Focused Program Award for Rare Melanoma Research

Summary: Supports a multidisciplinary research program of at least two, but not more than three, distinct but complementary research projects addressing an overarching question relevant to rare melanomas.

Distinctive Features:

·        *New for FY25* This funding mechanism is a partnering mechanism, requiring an Initiating Principal Investigator (PI) and at least one, but not more than two, Partnering PIs, see Figure 1.

•      Each named PI is expected to be a Project Leader for one of the proposed research projects. If recommended for funding, each PI will be named on separate awards to the recipient organization(s).

·        *New for FY25* After submitting the required pre-application, investigators must receive an invitation to submit a full application.

•      Only the Initiating PI will submit a pre-application. All PIs will need to submit full applications. The Partnering PI(s)’s application is an abbreviated package specific to their proposed research project.

·        Clinical trials are allowed.

·        Investigators are encouraged, but not required, to form collaborative relationships with the rare melanoma consumer community to maximize the impact and translatability of the research for the benefit of the intended community(ies).

Summary: Supports a multidisciplinary research program of at least two, but not more than three, distinct but complementary research projects addressing an overarching question relevant to rare melanomas.

Distinctive Features:

·        *New for FY25* This funding mechanism is a partnering mechanism, requiring an Initiating Principal Investigator (PI) and at least one, but not more than two, Partnering PIs, see Figure 1.

•      Each named PI is expected to be a Project Leader for one of the proposed research projects. If recommended for funding, each PI will be named on separate awards to the recipient organization(s).

·        *New for FY25* After submitting the required pre-application, investigators must receive an invitation to submit a full application.

•      Only the Initiating PI will submit a pre-application. All PIs will need to submit full applications. The Partnering PI(s)’s application is an abbreviated package specific to their proposed research project.

·        Clinical trials are allowed.

·        Investigators are encouraged, but not required, to form collaborative relationships with the rare melanoma consumer community to maximize the impact and translatability of the research for the benefit of the intended community(ies).